LamontJordanBarlowMD(He/Him)

Urology • New York, NY

Minimally Invasive Surgery, Surgical Oncology

Physician

Join to view full profile

Dr. Barlow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Barlow's full profile

Already have an account?

Office
423 E 23rd St
18086-aS
New York, NY 10010
Phone+1 212-686-7500
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Urologic Surgical Oncology, 2016 - 2018
New York Presbyterian Hospital (Columbia Campus)Residency, Urology, 2010 - 2016
Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Harvard UniversityBA, Biochemical Sciences, 2001 - 2005

Certifications & Licensure

NY State Medical License 2016 - 2026
American Board of Urology Urology

Clinical Trials

Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer Start of enrollment: 2007 Dec 01
Unknown status
Phase 1, Phase 2
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676) Start of enrollment: 2018 Dec 24
Recruiting
Phase 3
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) Start of enrollment: 2023 Mar 23
Recruiting
Phase 3

Publications & Presentations

PubMed

12 citations
The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.
Weisi Liu, Kevin P Newhall, Francesca Khani, LaMont Barlow, Duy Nguyen, Lilly Gu, Ken Eng, Bhavneet Bhinder, Manik Uppal, Charlotte Récapet, Andrea Sboner, Susan R Ros...> ;Cancer Research. 2023 Feb 15
EDITORIAL COMMENT.
LaMont J Barlow> ;Urology. 2022 Apr 1
Editorial Comment.
LaMont J Barlow, Gary D Steinberg> ;The Journal of Urology. 2021 Nov 1
3 citations
Racial and ethnic representation in primary research contributing to pelvic organ prolapse treatment guidelines.
Caroline Brandon, LaMont J Barlow, Cheongeun Oh, Andrew Sackrison, Benjamin M. Brucker> ;International Urogynecology Journal. 2021 Sep 27
A National Assessment of the Association Between Patient Race and Physician Visit Time During New Outpatient Urology Consultations.
LaMont J Barlow, Nnenaya A. Mmonu, Danil V. Makarov, Allison Sugarman, Richard S. Matulewicz> ;Urology. 2021 Aug 8
2 citations
Non-muscle-invasive Bladder Cancer Management During BCG Shortages: NYU Case of the Month, February 2020.
LaMont J Barlow> ;Reviews in Urology. 2020 Jan 1
439 citations
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee, Wenhuo Hu, Justin T. Matulay, Mark V. Silva, Tomasz Owczarek, Kwanghee Kim, Chee Wai Chua, La Mont J. Barlow, Cyriac Kandoth, Alanna B. Williams, Sarah ...> ;Cell. 2018 Apr 5
116 citations
The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study.
David M. Golombos, Abimbola Ayangbesan, Padraic O'Malley, Patrick Lewicki, LaMont Barlow, Christopher E. Barbieri, Chrystal Chan, Casey DuLong, Galeb Abu-Ali, Curtis H...> ;Urology. 2018 Jan 1
21 citations
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
Christopher R. Haas, LaMont J. Barlow, Gina M. Badalato, G. Joel DeCastro, Mitchell C. Benson, James M. McKiernan> ;The Journal of Urology. 2016 Jun 1
2 citations
The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes Following Radical Cystectomy for Urothelial Cancer.
Danny Lascano, Julia B Finkelstein, LaMont J Barlow, Daniel Kabat, Arindam RoyChoudhury, Jorge R Caso, G Joel DeCastro, William Gold, James M McKiernan> ;Urology. 2015 Dec 1
54 citations
Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmett...
James M. McKiernan, Dara Holder, Rashed Ghandour, LaMont J. Barlow, Jennifer Ahn, Max Kates, Gina M. Badalato, Arindam RoyChoudhury, G. Joel DeCastro, Mitchell C. Benson> ;The Journal of Urology. 2014 Dec 1
242 citations
Single luminal epithelial progenitors can generate prostate organoids in culture
Chee Wai Chua, Maho Shibata, Ming Lei, Roxanne Toivanen, LaMont J. Barlow, Sarah K. Bergren, Ketan K. Badani, James M. McKiernan, Mitchell C. Benson, Hanina Hibshoosh,...> ;Nature Cell Biology. 2014 Oct 1
16 citations
SnapShot: Prostate cancer.
LaMont J. Barlow, Michael M. Shen> ;Cancer Cell. 2013 Sep 9
76 citations
Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy
LaMont J. Barlow, James M. McKiernan, Mitchell C. Benson> ;The Journal of Urology. 2013 Mar 1
6 citations
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer.
LaMont J. Barlow, Mitchell C. Benson> ;Current Urology Reports. 2013 Feb 3
30 citations
Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma.
Nicholas Donin, Lara K. Suh, LaMont J. Barlow, Gregory W. Hruby, Jeffrey H. Newhouse, James M. McKiernan> ;BJU International. 2012 Feb 1
24 citations
A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer
Matthew S. Wosnitzer, Gregory W. Hruby, Alana M. Murphy, LaMont J. Barlow, Carlos Cordon-Cardo, Mahesh M. Mansukhani, Daniel P. Petrylak, Mitchell C. Benson, James M. ...> ;Cancer. 2012 Jan 15
50 citations
A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guérin Refractory Nonmuscle Invasive Bladder Cancer
James M. McKiernan, LaMont J. Barlow, Melissa A. Laudano, Mark Mann, Daniel P. Petrylak, Mitchell C. Benson> ;The Journal of Urology. 2011 Aug 1
47 citations
Serum tumor markers in the evaluation of male germ cell tumors.
LaMont J. Barlow, Gina M. Badalato, James M. McKiernan> ;Nature Reviews. Urology. 2010 Nov 1
17 citations
Single Institutional Experience with Nephron-sparing Surgery for Pathologic Stage T3bNxM0 Renal Cell Carcinoma Confined to the Renal Vein
Solomon L. Woldu, LaMont J. Barlow, Trushar Patel, Greg Hruby, Mitchell C. Benson, James M. McKiernan> ;Urology. 2010 Sep 1
78 citations
Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis
LaMont J. Barlow, Ruslan Korets, Melissa A. Laudano, Mitchell C. Benson, James M. McKiernan> ;BJU International. 2010 Aug 1
Has the advent of minimally invasive surgery altered the risk profile of patients undergoing prostatectomy
LaMont J. Barlow, Mark Mann, Ketan K. Badani, Mitchell C. Benson, James M. McKiernan> ;Urology. 2010 Feb 1
7 citations
Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG.
La Mont J. Barlow, Catherine M. Seager, Mitchell C. Benson, James M. McKiernan> ;Urologic Oncology. 2010 Jan 1
11 citations
The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy
LaMont J. Barlow, Gina M. Badalato, Talha Bashir, Mitchell C. Benson, James M. McKiernan> ;BJU International. 2009 Oct 26
2 citations
The Case of a Poorly Differentiated Gastric Adenocarcinoma Disguised as a Testicular Germ Cell Tumor in a 34-year-old Male
LaMont J. Barlow, Stephen A. Poon, James M. McKiernan> ;Urology. 2009 Oct 1
Join now to see all

Press Mentions

Bringing Bladder Cancer into FocusApril 2nd, 2017

Hospital Affiliations

Veterans Affairs New York Harbor Healthcare SystemBrooklyn, New York